Lachman has been providing
both onsite and remote
support to our clients
for many years.

Review Support Offerings
The Lachman Difference

The most efficient services.
The most qualified professionals.

Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA consultants and industry experts has offered compliance, regulatory affairs, and science & technology services to clients around the world.

Learn More About Us

Stay in the know

Sign up today for the Lachman Consultants blog.

Get the latest news on industry compliance, regulatory affairs, technical services, and a whole lot more.

    AREAS SERVED BY LACHMAN CONSULTANTS

    ADVANCE. CONFIDENTLY.

    As long-standing leaders in technical and regulatory consulting services, Lachman Consultants provides both experience and excellence through an unmatched team of respected industry professionals and SMEs.

    Mock FDA Inspections

    Are you fully prepared for an inspection at your facility?

    Our team of experienced ex-FDA investigators offer comprehensive mock FDA inspection services to help you prepare for an actual FDA inspection. Our team of experts will conduct a thorough inspection of your facility, review your documentation, and provide you with valuable feedback on areas that need improvement to ensure compliance with FDA regulations – both remotely and on-site.

    Learn More About Mock FDA Inspections

    OnCall Image

    Recent Posts

    The Lachman Consultants Blog

    The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.

    Middle age senior hoary doctor man texting using smartphone over isolated background screaming proud and celebrating victory and success very excited, cheering emotion

    December 2024 Brought Gifts for ANDA Approval Actions (Unofficially)

    The OGD had some late-month stocking stuffers as it issued 68 full-app...
    Read More
    I make a list at the start of each day

    Logbook Review: Too Simple To Automate?

    The logbook is the original audit trail mechanism as predicated in Eud...
    Read More
    The Tirzepatide Chapter Three Rears Its Head

    The Tirzepatide Chapter Three Rears Its Head – What Happens Now?

    According to Fraiser Kansteiner’s article published on January 2, ...
    Read More
    Testing substances

    FDA Issues Draft Guidance to Assist in Compliance with 21 CFR 211.110

    The Code of Federal Regulations at 211.110 is titled “Sampling and t...
    Read More
    Close up shot red darts arrows in the target of dartboard center on dark blue sky background. Business target or goal success and winner concept.

    FDA Updates List of Off-Patent, Off-Exclusivity Drug Products With No Approved ANDAs

    Twice a year, the FDA publishes an update of the List of Off‑Patent,...
    Read More
    business man looking for solution, understanding and clarity about complex problem

    Buprenorphine Back in the News Again!

    Just a week or so ago, there was a significant concern raised regardin...
    Read More
    ADVANCE CONFIDENTLY
    Contact Us Today